ACT Lung Health Intervention: Phase Two
Start Date
11/4/2025
Completion Date
12/31/2026
Summary
This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
Detailed Description
This two-arm stratified randomized clinical trial is to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer. Participants will be randomized into one of two groups: Group A: ACT Lung Health Intervention versus Group B: Standard Care. Randomization means a participant is placed into a study group by chance. The research study procedures include screening for eligibility, questionnaires, and saliva tests. It is expected participation in this study will last about 6 months. About 50 participants are expected to take part in this research study. The National Cancer Institute is providing funding for this trial.
Eligibility Criteria
Age Range: 18 years to 100 years
Interventions
ACT Lung Health Intervention
Conditions
Locations
Dana-Farber Cancer Institute
Boston, Massachusetts 02115
United States
University of Massachusetts-Boston
Boston, Massachusetts 02125
United States